Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jun 2, 2022

50715_rns_2022-06-02_29478b6e-8491-4fcb-ad55-a8cc9c824486.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

2 June 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description
of relevant
securities
Nature of dealings Purchase
/ Sale
Total
number
of shares
involved
Total
amount paid
/ received
Highest (H)
prices paid
/ received
Lowest (L)
prices paid
/ received
China
International
Capital
Corporation
Limited
1 June 2022 Ordinary
shares
Disposal of the underlying shares
received from the redemption of
pre-existing index-tracking ETFs as a
result of unsolicited client requests
Sale 600 $23,592.0000 $39.3200 $39.3200

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror.

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Dealings were made for its own account.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.